PRO-POWER: Hypertension With Risk Factors for a Duration of 24 Weeks With Micardis 80mg/Micardis Plus 80mg/12.5mg

Hypertensive patients in the Kingdom of Saudi Arabia, Egypt and United Arab Emirates

Inclusion criteria:

• Male or female
• Aged 20 to 80 years old.
• adult with essential hypertension - either newly diagnosed and untreated, or previously treated and uncontrolled
• Sitting blood pressure: systolic BP > 140 mmHg but < 180 mmHg, and/or diastolic BP > 90 mmHg but < 110 mmHg)
• At least one cardiovascular known risk factor other than hypertension: diabetes/hyperglycaemia, cholesterol /dyslipidemia, a previous cardiovascular event, target organ damage, family history of hypertension or cardiovascular diseases, old age defined as > 55 years (Males), > 65 years (Females), smoking, overweight or obese patients or a combination of above risk factors
• Patients who are assessed to benefit from the intake of angiotensin II receptor blocker (ARB) monotherapy or as add-on medication

Exclusion criteria:

• Patients with contraindications to Telmisartan use (as per the Micardis® Tablets package insert).
• Known hypersensitivity to the active ingredient or to any of the excipients of Micardis® .
• Any other clinical condition which, in the opinion of the attending physician, would not allow safe administration of the study medications.
• Patients participating in any other clinical trial.
• Patients already on Micardis® alone or combination
• Pregnant females, or females breast feeding.